Keyphrases
Cancer Treatment
100%
Tumor Site
100%
Engineered T Cells
100%
Chimeric Antigen Receptor T Cells (CAR-T)
66%
T Cells
66%
Tumor
33%
Interleukin-13 (IL-13)
33%
Antitumor Effect
33%
Physiologic
33%
Interleukin-10
33%
Tumor Response
33%
Expression Pattern
33%
Adoptive Transfer
33%
Safety Profile
33%
Antitumor Efficacy
33%
Pancreatic Cancer
33%
Paucity
33%
Costimulation
33%
Proof of Concept Study
33%
Tumor Selectivity
33%
Refractory Disease
33%
Endodomain
33%
Engineering Approach
33%
Genetically Modified T Cells
33%
Cell-responsive
33%
Programmed Death-ligand 1 (PD-L1)
33%
Inhibitory Molecules
33%
Prostate Stem Cell Antigen
33%
T Cell Signaling
33%
Immunosuppressive Cytokines
33%
Off-target Toxicity
33%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Cytokine
40%
Stem Cell
20%
Signal Transduction
20%
Chimeric Antigen Receptor
20%
Transgenics
20%
PD-L1
20%
Medicine and Dentistry
T-Cell Signaling
14%
Prostate Stem Cell Antigen
14%